CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID...
Phase 3
Detroit, Michigan, United States and 19 other locations
The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...
Phase 3
Southfield, Michigan, United States and 217 other locations
This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI--...
Phase 2
Sterling Heights, Michigan, United States and 54 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
Novi, Michigan, United States and 214 other locations
be tolerated for treatment of pregnant women with mild or moderate COVID-19 compared to non-pregnant women with mild or moderate CO-...
Phase 1
Farmington Hills, Michigan, United States of America and 32 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Ann Arbor, Michigan, United States and 66 other locations
The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...
Phase 3
Farmington Hills, Michigan, United States of America and 162 other locations
study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...
Phase 2, Phase 3
Detroit, Michigan, United States and 109 other locations
the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...
Phase 4
Ann Arbor, Michigan, United States and 39 other locations
This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...
Phase 2, Phase 3
Grosse Pointe Woods, Michigan, United States and 90 other locations
Clinical trials
Research sites
Resources
Legal